These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11132019)

  • 1. Changes in erythrocyte calcium and potassium in patients during HD and CAPD.
    Paraskevopoulos A; Agroyannis B; Kopelias L; Tzanatos E; Tsomi A; Dalamanga A; Katsoudas S; Petras D; Voudiclari S
    Int J Artif Organs; 2000 Nov; 23(11):750-3. PubMed ID: 11132019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is erythrocyte damage prevented by gardos effect in hemodialyzed uremic patients?
    Agroyannis B; Paraskevopoulos A; Kopelias I; Tzanatos H; Kapetanaki A; Tsomi A
    Artif Organs; 2000 Sep; 24(9):743-5. PubMed ID: 11012545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis.
    Pastor MC; Sierra C; Bonal J; Teixidó J
    Am J Nephrol; 1993; 13(4):238-43. PubMed ID: 8267019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in calcium kinetic pattern between CAPD and HD patients.
    Kurz P; Tsobanelis T; Roth P; Werner E; Ewald U; Grützmacher P; Schoeppe W; Vlachojannis J
    Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
    Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
    Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Zima T; Mestek O; Nĕmecek K; Bártová V; Fialová J; Tesar V; Suchánek M
    Blood Purif; 1998; 16(5):253-60. PubMed ID: 9917533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
    Sotirakopoulos N; Tsitsios T; Stambolidou M; Athanasiou G; Peiou M; Kokkinou V; Mavromatidis K
    Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD.
    Romanini D; Gazo A; Bellazzi R; de Vincenzi A; Nai M; Santagostino M
    Adv Perit Dial; 1994; 10():267-9. PubMed ID: 7999842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in erythrocyte Ca2+, K+, and Mg2+ content in uremic patients on CAPD.
    Agroyannis B; Fourtounas C; Kopelias I; Paraskevopoulos A; Bougatsos G; Katsoudas S; Tzanatos H; Tsomi A; Voudiclari S
    Perit Dial Int; 2002; 22(2):269-72. PubMed ID: 11990416
    [No Abstract]   [Full Text] [Related]  

  • 13. Pruritus in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Balaskas EV; Chu M; Uldall RP; Gupta A; Oreopoulos DG
    Perit Dial Int; 1993; 13 Suppl 2():S527-32. PubMed ID: 8399656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
    Hampson G; Vaja S; Evans C; Chesters CA; Pettit R; Evans W; Thomas D; Seed PT; Fraser WD
    Nephron; 2002 May; 91(1):94-102. PubMed ID: 12021525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
    Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A
    Nephron; 1998; 78(4):395-402. PubMed ID: 9578065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with CAPD.
    Bertoli SV; di Belgiojoso GB; Trezzi M; Scorza D; Barone MT; Poggio M; Rossi E; Landriani N; Genderini A
    Adv Perit Dial; 1995; 11():127-30. PubMed ID: 8534685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.
    Pietrzak I; Bladek K; Bulikowski W
    Magnes Res; 2002 Dec; 15(3-4):229-36. PubMed ID: 12635877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonic gallbladder function in chronic kidney disease: does predialysis, hemodialysis, or CAPD affect it?
    Bektas A; Belet U; Kelkitli E; Bakir T; Acikgoz A; Akpolat T
    Ren Fail; 2005; 27(6):677-81. PubMed ID: 16350817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte Na-stimulated Mg transport in uremic patients undergoing CAPD.
    Quarello F; Guarena C; Boero R; Bonello F; Belardi P; Maffei S; Beltrame G; Reinero G; Piccoli G
    Adv Perit Dial; 1990; 6():207-10. PubMed ID: 1982810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.